BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Dato F, Iorio R. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone? World J Gastroenterol 2024; 30(17): 2294-2297 [PMID: 38813053 DOI: 10.3748/wjg.v30.i17.2294]
URL: https://www.wjgnet.com/2219-2824/full/v30/i17/2294.htm
Number Citing Articles
1
Yupeng Wang, Shuangxing Li, Tianqi Ren, Yikun Zhang, Bo Li, Xingchao Geng. Mechanism of emodin in treating hepatitis B virus-associated hepatocellular carcinoma: network pharmacology and cell experimentsFrontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1458913
2
Yongbin Wu, Guifang Tang, Jian Wen, Ying Wan, Yufei Wang, Ling Li. Serum hepatitis B virus RNA in low-level viremia of chronic hepatitis B: clinical features and association with virological responseVirology Journal 2025; 22(1) doi: 10.1186/s12985-025-02712-y